Your browser doesn't support javascript.
loading
Recovering from COVID-19 (ReCOV): Feasibility of an Allied-Health-Led Multidisciplinary Outpatient Rehabilitation Service for People with Long COVID.
D'Souza, Aruska N; Merrett, Myvanwy; Griffin, Hilda; Tran-Duy, An; Struck, Carly; Fazio, Timothy N; Juj, Genevieve; Granger, Catherine L; Peiris, Casey L.
Afiliação
  • D'Souza AN; Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia.
  • Merrett M; Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia.
  • Griffin H; Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia.
  • Tran-Duy A; Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Struck C; Methods and Implementation Support for Clinical and Health Research (MISCH) Hub, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Fazio TN; Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia.
  • Juj G; Health Intelligence Unit, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia.
  • Granger CL; Electronic Medical Records, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia.
  • Peiris CL; Melbourne Medical School, The University of Melbourne, Parkvillle, VIC 3010, Australia.
Article em En | MEDLINE | ID: mdl-39063534
ABSTRACT

BACKGROUND:

A multidisciplinary approach is required for the management of long COVID. The aim of this study was to determine the feasibility (demand, implementation, practicality, acceptability, and limited efficacy) of an allied-health-led multidisciplinary symptom management service (ReCOV) for long COVID.

METHODS:

A single-group observational cohort feasibility study was conducted to determine demand (referrals), acceptability (survey), implementation (waitlist times, health professions seen), practicality (adverse events), and limited efficacy (admission and discharge scores from the World Health Organization Disability Assessment Scale, Brief Illness Perception Questionnaire (BIPQ), Patient Health Questionnaire, and EuroQol 5D-5L). Data are presented as median [interquartile range] or count (percentage).

RESULTS:

During the study, 143 participants (aged 42.00 [32.00-51.00] years, 68% women) participated in ReCOV. Participants were waitlisted for 3.86 [2.14-9.86] weeks and engaged with 5.00 [3.00-6.00] different health professionals. No adverse events occurred. The thematic analysis revealed that ReCOV was helpful but did not fully meet the needs of all participants. Limited efficacy testing indicated that participants had improved understanding and control (p < 0.001) of symptoms (BIPQ) and a small improvement in EQ VAS score (median difference 5.50 points [0.00-25.00], p = 0.004]).

CONCLUSIONS:

A multidisciplinary service was safe and mostly acceptable to participants for the management of long COVID. Further research should investigate the clinical and cost effectiveness of such a service, including optimal service duration and patient outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudos de Viabilidade / COVID-19 Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Environ Res Public Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudos de Viabilidade / COVID-19 Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Environ Res Public Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália